Back to Search
Start Over
Sensory-mechanical effects of a dual bronchodilator and its anticholinergic component in COPD.
- Source :
-
Respiratory Physiology & Neurobiology . Jan2018, Vol. 247, p116-125. 10p. - Publication Year :
- 2018
-
Abstract
- This randomized, double-blind, crossover study examined the physiological rationale for using a dual long-acting bronchodilator (umeclidinium/vilanterol (UME/VIL)) versus its muscarinic-antagonist component (UME) as treatment for dyspnea and exercise intolerance in moderate COPD. After each 4-week treatment period, subjects performed pulmonary function and symptom-limited constant-work rate cycling tests with diaphragm electromyogram (EMGdi), esophageal (Pes), gastric (Pga) and transdiaphragmatic (Pdi) pressure measurements. Fourteen subjects completed the study. Both treatments improved spirometry and airway resistance. UME/VIL had larger increases in FEV 1 (+0.14 ± 0.23 L, p < 0.05) but no added reduction in lung hyperinflation compared with UME. Isotime during exercise after UME/VIL versus UME (p < 0.05): “unpleasantness of breathing” fell 0.8 ± 1.3 Borg units; mean expiratory flow and ventilation increased; Pdi and Pga decreased. There were no treatment differences in endurance time, breathing pattern, operating lung volumes, inspiratory neural drive (EMGdi) or respiratory muscle effort (Pes swings) during exercise. UME/VIL compared with UME was associated with reduced breathing unpleasantness reflecting improved airway and respiratory muscle function during exercise. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 15699048
- Volume :
- 247
- Database :
- Academic Search Index
- Journal :
- Respiratory Physiology & Neurobiology
- Publication Type :
- Academic Journal
- Accession number :
- 126313230
- Full Text :
- https://doi.org/10.1016/j.resp.2017.10.001